MoneyWorks4Me

Gland Pharma - Quaterly Results

11 Aug 2026 Evaluate
A fair growth of 23.85% in the revenue at Rs. 12866.40 millions was reported in the June 2026 quarter as compared to Rs. 10388.35 millions during year-ago period.Good  Net Profit growth of 35.33% reported above the corresponding previous quarter figure of Rs. 2692.58 millions to Rs. 3643.91 millioins.Operating profit for the quarter ended June 2026 rose to 5323.34 millions as compared to 4135.86 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 12866.40 10388.35 23.85 12866.40 10388.35 23.85 45520.92 41161.49 10.59
Other Income 588.21 547.41 7.45 588.21 547.41 7.45 3038.97 2150.75 41.30
PBIDT 5323.34 4135.86 28.71 5323.34 4135.86 28.71 19669.73 16576.93 18.66
Interest 6.91 74.35 -90.71 6.91 74.35 -90.71 180.73 228.37 -20.86
PBDT 5316.43 4061.51 30.90 5316.43 4061.51 30.90 19245.54 16348.56 17.72
Depreciation 439.53 437.68 0.42 439.53 437.68 0.42 1762.43 1692.71 4.12
PBT 4876.90 3623.83 34.58 4876.90 3623.83 34.58 17483.11 14655.85 19.29
TAX 1232.99 931.25 32.40 1232.99 931.25 32.40 4487.60 3758.32 19.40
Deferred Tax -18.93 -1.46 1196.58 -18.93 -1.46 1196.58 -38.29 91.24 -141.97
PAT 3643.91 2692.58 35.33 3643.91 2692.58 35.33 12995.51 10897.53 19.25
Equity 164.96 164.76 0.12 164.96 164.76 0.12 164.76 164.76 0.00
PBIDTM(%) 41.37 39.81 3.92 41.37 39.81 3.92 43.21 40.27 7.29
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..